SEDLÁKOVÁ, Veronika, Marc RUEL and Erik SUURONEN. Therapeutic Use of Bioengineered Materials for Myocardial Infarction. In Alarcon E., Ahumada M. (eds.). Nanoengineering Materials for Biomedical Uses. Cham: Springer, 2019, p. 161-193. 1. ISBN 978-3-030-31260-2. Available from: https://dx.doi.org/10.1007/978-3-030-31261-9_9.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Therapeutic Use of Bioengineered Materials for Myocardial Infarction
Authors SEDLÁKOVÁ, Veronika, Marc RUEL and Erik SUURONEN.
Edition Cham, Nanoengineering Materials for Biomedical Uses, p. 161-193, 33 pp. 1. 2019.
Publisher Springer
Other information
Original language English
Type of outcome Chapter(s) of a specialized book
Field of Study 30400 3.4 Medical biotechnology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
Publication form printed version "print"
WWW URL
Organization unit Faculty of Medicine
ISBN 978-3-030-31260-2
Doi http://dx.doi.org/10.1007/978-3-030-31261-9_9
Keywords in English Regenerative Medicine Tissue Engineering Biomimetic Composites Nanomaterials for Biomedicine Biocompatible Nanomaterials Engineering of Materials for Biocompatibility Nanostructures for Repair Heart Tissue Regeneration
Tags topvydavatel
Changed by Changed by: MUDr. Veronika Sedláková, Ph.D., učo 116733. Changed: 26/1/2022 12:44.
Abstract
Cardiovascular disease is a leading cause of worldwide mortality. Despite the success of current therapies for acute myocardial infarction (MI), many patients still suffer irreversible damage, and the prevalence of heart failure is growing. After MI, the extracellular matrix (ECM) of the damaged myocardium is modified to produce scar tissue. This remodeling reduces the efficacy of therapies and also hinders endogenous repair mechanisms. Therefore, a strategy to prevent adverse remodeling and provide a suitable ECM environment that supports cells, tissue repair and functional restoration may lead to a superior therapeutic outcome in MI patients. Bioengineered materials are an attractive approach for achieving this. Herein, we review current research on materials that can act as a biomimetic matrix for supporting cellular repair in the post-MI heart. We also examine how nanomaterials are being used to treat the damaged heart. Finally, we provide an overview of the breakthroughs and limitations of biomaterial therapies for cardiac repair.
PrintDisplayed: 31/5/2024 12:22